Cargando…
S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428398/ http://dx.doi.org/10.1097/01.HS9.0000967312.24545.68 |
| _version_ | 1785090459532525568 |
|---|---|
| author | Martelli, Maurizio Ceriani, Luca Zucca, Emanuele Kryachok, Irina Ciccone, Giovannino Ricardi, Umberto Botto, Barbara Balzarotti, Monica Tucci, Alessandra Veronica Usai, Sara Pennese, Elsa Arcaini, Luca Dabrowska-Iwanicka, Anna José María Ferreri, Andrés Marli, Francesco Zhao, Weili Hodgson, David Ionescu, Codruta Rigacci, Luigi Cellini, Claudia Stelitano, Caterina Zaja, Francesco Guarini, Attilio Spina, Michele Fossa, Alexander Cwynarski, Kate Mikhaeel, N. George Jerkeman, Mats Janíková, Andrea Huettmann, Andreas Silva, Maria Gomes Da Stevens, Don Petrucci, Luigi Barrington, Sally Malkowski, Bogdan Metser, Ur Versari, Annibale Bagni, Oreste Chauvie, Stephane Cozens, Kelly Perticone, Sonia Ielmini, Nicoletta Cavalli, Franco Gosodarowicz, Mary Johnson, Peter W. Davies, Andrew |
| author_facet | Martelli, Maurizio Ceriani, Luca Zucca, Emanuele Kryachok, Irina Ciccone, Giovannino Ricardi, Umberto Botto, Barbara Balzarotti, Monica Tucci, Alessandra Veronica Usai, Sara Pennese, Elsa Arcaini, Luca Dabrowska-Iwanicka, Anna José María Ferreri, Andrés Marli, Francesco Zhao, Weili Hodgson, David Ionescu, Codruta Rigacci, Luigi Cellini, Claudia Stelitano, Caterina Zaja, Francesco Guarini, Attilio Spina, Michele Fossa, Alexander Cwynarski, Kate Mikhaeel, N. George Jerkeman, Mats Janíková, Andrea Huettmann, Andreas Silva, Maria Gomes Da Stevens, Don Petrucci, Luigi Barrington, Sally Malkowski, Bogdan Metser, Ur Versari, Annibale Bagni, Oreste Chauvie, Stephane Cozens, Kelly Perticone, Sonia Ielmini, Nicoletta Cavalli, Franco Gosodarowicz, Mary Johnson, Peter W. Davies, Andrew |
| author_sort | Martelli, Maurizio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428398 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283982023-08-17 S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) Martelli, Maurizio Ceriani, Luca Zucca, Emanuele Kryachok, Irina Ciccone, Giovannino Ricardi, Umberto Botto, Barbara Balzarotti, Monica Tucci, Alessandra Veronica Usai, Sara Pennese, Elsa Arcaini, Luca Dabrowska-Iwanicka, Anna José María Ferreri, Andrés Marli, Francesco Zhao, Weili Hodgson, David Ionescu, Codruta Rigacci, Luigi Cellini, Claudia Stelitano, Caterina Zaja, Francesco Guarini, Attilio Spina, Michele Fossa, Alexander Cwynarski, Kate Mikhaeel, N. George Jerkeman, Mats Janíková, Andrea Huettmann, Andreas Silva, Maria Gomes Da Stevens, Don Petrucci, Luigi Barrington, Sally Malkowski, Bogdan Metser, Ur Versari, Annibale Bagni, Oreste Chauvie, Stephane Cozens, Kelly Perticone, Sonia Ielmini, Nicoletta Cavalli, Franco Gosodarowicz, Mary Johnson, Peter W. Davies, Andrew Hemasphere Plenary Abstracts Session Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428398/ http://dx.doi.org/10.1097/01.HS9.0000967312.24545.68 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Plenary Abstracts Session Martelli, Maurizio Ceriani, Luca Zucca, Emanuele Kryachok, Irina Ciccone, Giovannino Ricardi, Umberto Botto, Barbara Balzarotti, Monica Tucci, Alessandra Veronica Usai, Sara Pennese, Elsa Arcaini, Luca Dabrowska-Iwanicka, Anna José María Ferreri, Andrés Marli, Francesco Zhao, Weili Hodgson, David Ionescu, Codruta Rigacci, Luigi Cellini, Claudia Stelitano, Caterina Zaja, Francesco Guarini, Attilio Spina, Michele Fossa, Alexander Cwynarski, Kate Mikhaeel, N. George Jerkeman, Mats Janíková, Andrea Huettmann, Andreas Silva, Maria Gomes Da Stevens, Don Petrucci, Luigi Barrington, Sally Malkowski, Bogdan Metser, Ur Versari, Annibale Bagni, Oreste Chauvie, Stephane Cozens, Kelly Perticone, Sonia Ielmini, Nicoletta Cavalli, Franco Gosodarowicz, Mary Johnson, Peter W. Davies, Andrew S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) |
| title | S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) |
| title_full | S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) |
| title_fullStr | S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) |
| title_full_unstemmed | S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) |
| title_short | S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559) |
| title_sort | s101: omission of radiotherapy in primary mediastinal b-cell lymphoma patients following complete metabolic response to standard immunochemotherapy: results of the ielsg37 randomised trial (nct01599559) |
| topic | Plenary Abstracts Session |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428398/ http://dx.doi.org/10.1097/01.HS9.0000967312.24545.68 |
| work_keys_str_mv | AT martellimaurizio s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT cerianiluca s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT zuccaemanuele s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT kryachokirina s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT cicconegiovannino s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT ricardiumberto s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT bottobarbara s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT balzarottimonica s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT tuccialessandra s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT veronicausaisara s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT penneseelsa s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT arcainiluca s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT dabrowskaiwanickaanna s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT josemariaferreriandres s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT marlifrancesco s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT zhaoweili s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT hodgsondavid s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT ionescucodruta s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT rigacciluigi s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT celliniclaudia s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT stelitanocaterina s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT zajafrancesco s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT guariniattilio s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT spinamichele s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT fossaalexander s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT cwynarskikate s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT mikhaeelngeorge s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT jerkemanmats s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT janikovaandrea s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT huettmannandreas s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT silvamariagomesda s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT stevensdon s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT petrucciluigi s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT barringtonsally s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT malkowskibogdan s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT metserur s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT versariannibale s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT bagnioreste s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT chauviestephane s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT cozenskelly s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT perticonesonia s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT ielmininicoletta s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT cavallifranco s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT gosodarowiczmary s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT johnsonpeterw s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 AT daviesandrew s101omissionofradiotherapyinprimarymediastinalbcelllymphomapatientsfollowingcompletemetabolicresponsetostandardimmunochemotherapyresultsoftheielsg37randomisedtrialnct01599559 |